Neuroleptic Cardiomyopathy: Let’s Get Acquainted
Volume 1 - Issue 4
Volkov VP*
-
Author Information
Open or Close
- Tver center of judicial examinations, Russia
*Corresponding author:
Volkov VP, Tver center of judicial examinations, Russia, 170008, Tver A Zavidov St., 24, of. 6
Received: September 05, 2018; Published: September 11, 2018
DOI: 10.32474/LOJMS.2018.01.000117
Full Text
PDF
To view the Full Article Peer-reviewed Article PDF
Abstract
The presented mini-review summarizes the results of our
own research and rather rare literature data on the problem of
neuroleptic cardiomyopathy. The aspects of etiology, epidemiology,
clinical course, electrocardiographic signs and pathomorphology
of the disease are briefly considered. The question of nosological
independence of neuroleptic cardiomyopathy is raised. Neuroleptic
(antipsychotic) cardiomyopathy (NCMP) is a little known to a wide
range of doctors iatrogenic pathology. It is associated with a side
cardiotoxic effect of antipsychotic drugs [1-9]. The disease belongs
to secondary specific metabolic dilated cardiomyopathies [10-12]
and is characterized by diffusion damage of a myocardium, by
sharp decrease in its contractile function and by the progressing of
congestive chronic heart failure (CHF) [8,10,11,13-17].
Mini Review|
Refrences|